Division of Pulmonary & Critical Care Medicine.
Division of Behavioral Medicine and Clinical Psychology.
Health Psychol. 2020 Jun;39(6):509-518. doi: 10.1037/hea0000851. Epub 2020 Mar 23.
The purpose of this study was to evaluate associations between executive functioning and caregiver adherence monitoring with objective antihypertensive medication adherence over 24 months in adolescents with chronic kidney disease (CKD).
Adolescents ( = 97, 11-20 years old) with CKD taking antihypertensive medication and their caregivers were recruited from three pediatric nephrology clinics. At baseline, adolescents and caregivers reported on adolescents' executive functioning and caregivers reported on their adherence monitoring. Antihypertensive medication adherence was objectively assessed via electronic monitoring at baseline and every 6 months after for 24 months. Associations between executive functioning, caregiver monitoring, and longitudinal adherence were evaluated with linear mixed models.
Up to 38% of adolescents had elevated executive functioning scores indicating more severe impairments, with rates varying by scale and reporter (adolescent vs. caregiver). Caregiver monitoring showed a significant, negative association with adherence, but adolescents' executive functioning was not significantly associated with adherence. Neither variable was associated with the rate of change in adherence over time.
Given that adolescents' executive functioning was not associated with antihypertensive medication adherence or changes in adherence over time, adherence to daily pill-form medications may involve less cognitive effort than more complex medical regimens. Higher levels of caregiver monitoring were unexpectedly associated with lower adherence levels. This unanticipated finding may reflect increased caregiver monitoring efforts when faced with adolescents' medication nonadherence, but this finding warrants further investigation. Adolescents with CKD who are nonadherent may benefit from medication adherence-promoting strategies beyond increasing caregiver monitoring. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
本研究旨在评估执行功能和照护者依从性监测与青少年慢性肾脏病(CKD)患者 24 个月内客观降压药物依从性之间的关联。
从三家儿科肾病诊所招募了接受降压药物治疗的青少年(n=97,11-20 岁)及其照护者。在基线时,青少年及其照护者报告了青少年的执行功能,照护者报告了他们的依从性监测情况。在基线和之后的每 6 个月通过电子监测对降压药物依从性进行了 24 个月的客观评估。使用线性混合模型评估了执行功能、照护者监测与纵向依从性之间的关联。
多达 38%的青少年存在执行功能评分升高的情况,表明存在更严重的损伤,其发生率因量表和报告者(青少年与照护者)而异。照护者监测与依从性呈显著负相关,但青少年的执行功能与依从性无显著相关。两个变量均与随时间变化的依从率变化无关。
鉴于青少年的执行功能与降压药物依从性或随时间变化的依从性无关联,因此,每日服用药丸形式药物的依从性可能不需要认知上的太多努力,而不是更复杂的医疗方案。出乎意料的是,照护者监测水平较高与较低的依从水平相关。这种意外发现可能反映出照护者在面对青少年药物不依从时增加了监测努力,但这一发现需要进一步研究。非依从性的 CKD 青少年可能受益于除了增加照护者监测之外的促进药物依从性的策略。